Key Highlights
- Kathryn Lowell, BioMarin’s VP of Global Government Affairs, joins the board.
- Stephen Hatke, VP of Operations at Takeda, brings over 25 years of manufacturing expertise.
- Tina Self, Bayer’s SVP for Biologics Manufacturing, expands board’s operational insight.
- New members expected to drive innovation and strategic growth for California’s life science industry.
Source: Business Wire
Notable Quote
- “With deep knowledge of the healthcare industry, government policy, and pharmaceutical manufacturing, Ms. Lowell, Mr. Hatke, and Ms. Self offer invaluable insights that will ultimately foster and continue driving innovation across the state.” — Joe Panetta, President and CEO at Biocom California
SoHC's Take
Biocom California’s addition of Lowell, Hatke, and Self to its board signals a strengthened focus on healthcare policy, operational efficiency, and advanced pharmaceutical manufacturing. These leaders bring decades of combined expertise that will be instrumental in shaping the future of life sciences in California. Each new board member offers specialized knowledge—Lowell’s in policy and advocacy, Hatke’s in manufacturing transformation, and Self’s in biologics production—which align well with Biocom’s mission to support research, innovation, and economic growth across the state’s life science industry.
